Imagion Biosystems Ltd (ASX: IBX) — Healthcare · Share Price, Chart & Market Data
About: Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.02 (-5.56%)
IBXImagion Biosystems Ltd
Loading watchlist status…
Trade IBX now
Imagion Biosystems Ltd share price
IBX price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:01 am GMT+0
IBX price performance
-19.048%
5D
-19.048%
1M
-34.615%
YTD
30.769%
1Y
IBX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:01 am GMT+0
IBX details
IBX Market Signals